New clues about how the ovarian cancer tumor works to evade the body’s immune system could offer new leads for treatment and early diagnosis, Johns Hopkins researchers said.
Researchers found that fluid secretions from ovarian tumors, known as ascites, can suppress a specific immune system cell called natural killer T cells.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.